Lisa Stockdale

Pre-erythrocytic Malaria Clinical Trials

 As the Senior immunologist in the pre-erythrocytic malaria vaccine group, I coordinate the clinical immunology of all R21/Matrix-M vaccine trials. These include trials studying vaccine immunogenicity in populations with co-morbidities, different age groups, and using alternative dosing regimens.

 Having spent 5 years in Industry working in small molecule drug development, I completed a Master of International Public Health at York University, and a PhD in Tuberculosis Vaccine Immunology at London School of Hygiene and Tropical Medicine, before joining the Oxford Vaccine Group as a post-doc where I conducted research on Typhoid conjugate vaccine immunology and Covid-19 vaccine development and immunology. 

 I joined the Pre-erythrocytic Malaria group at the Jenner Institute in 2021. My research interests include correlates of vaccine-induced protection, investigation of mediators of antibody function, immunological interactions between different pathogens and sero-epidemiology.

I am an Early Career Researcher representative for the Medical Sciences Division and the Nuffield Department of Medicine and a lead of the Jenner Research Staff Network.